Pharmacogenetic Screening of the Gene Deletion and Duplications of CYP2D6

REFERENCES

• Abraham A. Genetic polymorphism of CYP2D6. Indian J. Pharmacol. 2001; 33: 147–169
   Google Scholar
• Armour J. A., Barton D. E., Cockburn D. J., Taylor G. R. The detection of large deletions or duplications in genomic DNA. Hum. Mutat. 2002; 20: 325–337
   PubMed Web of Science ®Google Scholar
• Barnes W. M. PCR amplification of up to 35-kb DNA with high fidelity and high yield from lambda bacteriophage templates. Proc. Natl. Acad. Sci. USA 1994; 91: 2216–2220
   PubMed Web of Science ®Google Scholar
• Bertilsson L., Dahl M. L., Dalen P., Al-Shurbaji A. Molecular genetics of CYP2D6: Clinical relevance with focus on psychotropic drugs. Br. J. Clin. Pharmacol. 2002; 53: 111–122
   PubMed Web of Science ®Google Scholar
• Bodin L., Beaune P. H., Loriot M. A. Determination of cytochrome P450 2D6 (CYP2D6) gene copy number by real-time quantitative PCR. J. Biomed. Biotechnol. 2005; 2005: 248–253
   PubMedGoogle Scholar
• Bradford L. D. CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants. Pharmacogenomics 2002; 3: 229–243
   PubMed Web of Science ®Google Scholar
• Broly F., Marez D., Sabbagh N., Legrand M., Millecamps S., Lo Guidice J. M., Boone P., Meyer U. A. An efficient strategy for detection of known and new mutations of the CYP2D6 gene using single strand conformation polymorphism analysis. Pharmacogenetics 1995; 5: 373–384
   PubMedGoogle Scholar
• Cheng S., Fockler C., Barnes W. M., Higuchi R. Effective amplification of long targets from cloned inserts and human genomic DNA. Proc. Natl. Acad. Sci. USA 1994; 91: 5695–5699
   PubMed Web of Science ®Google Scholar
• Daly A. K., Steen V. M., Fairbrother K. S., Idle J. R. CYP2D6 multiallelism. Methods Enzymol. 1996; 272: 199–210
   PubMed Web of Science ®Google Scholar
• Endrizzi K., Fischer J., Klein K., Schwab M., Nussler A., Neuhaus P., Eichelbaum M., Zanger U. M. Discriminative quantification of cytochrome P4502D6 and 2D7/8 pseudogene expression by TaqMan real-time reverse transcriptase polymerase chain reaction. Anal. Biochem. 2002; 300: 121–131
   PubMed Web of Science ®Google Scholar
• Eriksson S., Berg L. M., Wadelius M., Alderborn A. Cytochrome p450 genotyping by multiplexed real-time DNA sequencing with pyrosequencing technology. Assay Drug Dev. Technol. 2002; 1: 49–59
   PubMed Web of Science ®Google Scholar
• Gaedigk A., Blum M., Gaedigk R., Eichelbaum M., Meyer U. A. Deletion of the entire cytochrome P450 CYP2D6 gene as a cause of impaired drug metabolism in poor metabolizers of the debrisoquine/sparteine polymorphism. Am. J. Hum. Genet. 1991; 48: 943–950
   PubMed Web of Science ®Google Scholar
• Ginzinger D. G. Gene quantification using real-time quantitative PCR: An emerging technology hits the mainstream. Exp. Hematol. 2002; 30: 503–512
   PubMed Web of Science ®Google Scholar
• Giovannetti E., Mey V., Danesi R., Basolo F., Barachini S., Deri M., Del Tacca M. Interaction between gemcitabine and topotecan in human non-small-cell lung cancer cells: Effects on cell survival, cell cycle and pharmacogenetic profile. Br. J. Cancer 2005; 92: 681–689
   PubMed Web of Science ®Google Scholar
• Giulietti A., Overbergh L., Valckx D., Decallonne B., Bouillon R., Mathieu C. An overview of real-time quantitative PCR: Applications to quantify cytokine gene expression. Methods 2001; 25: 386–401
   PubMed Web of Science ®Google Scholar
• Gonzalez F. J., Skoda R. C., Kimura S., Umeno M., Zanger U. M., Nebert D. W., Gelboin H. V., Hardwick J. P., Meyer U. A. Characterization of the common genetic defect in humans deficient in debrisoquine metabolism. Nature 1988a; 331: 442–446
   PubMed Web of Science ®Google Scholar
• Gonzalez F. J., Vilbois F., Hardwick J. P., McBride O. W., Nebert D. W., Gelboin H. V., Meyer U. A. Human debrisoquine 4-hydroxylase (P450IID1): cDNA and deduced amino acid sequence and assignment of the CYP2D locus to chromosome 22. Genomics 1988b; 2: 174–179
   PubMedGoogle Scholar
• Gough A. C., Smith C. A., Howell S. M., Wolf C. R., Bryant S. P., Spurr N. K. Localization of the CYP2D gene locus to human chromosome 22q13.1 by polymerase chain reaction, in situ hybridization, and linkage analysis. Genomics 1993; 15: 430–432
   PubMed Web of Science ®Google Scholar
• Hanna I. H., Dawling S., Roodi N., Guengerich F. P., Parl F. F. Cytochrome P450 1B1 (CYP1B1) pharmacogenetics: association of polymorphisms with functional differences in estrogen hydroxylation activity. Cancer Res. 2000; 60: 3440–3444
   PubMed Web of Science ®Google Scholar
• Heim M., Meyer U. A. Genotyping of poor metabolisers of debrisoquine by allele-specific PCR amplification. Lancet 1990; 336: 529–532
   PubMed Web of Science ®Google Scholar
• Heim M. H., Meyer U. A. Evolution of a highly polymorphic human cytochrome P450 gene cluster: CYP2D6. Genomics 1992; 14: 49–58
   PubMed Web of Science ®Google Scholar
• Hengen P. N. Methods and reagents. Long and accurate PCR. TIBS 1994; 19: 341–342
   PubMed Web of Science ®Google Scholar
• Hersberger M., Marti-Jaun J., Rentsch K., Hanseler E. Rapid detection of the CYP2D6*3, CYP2D6*4, and CYP2D6*6 alleles by tetra-primer PCR and of the CYP2D6*5 allele by multiplex long PCR. Clin. Chem. 2000; 46: 1072–1077
   PubMed Web of Science ®Google Scholar
• Hiratsuka M., Agatsuma Y., Omori F., Narahara K., Inoue T., Kishikawa Y., Mizugaki M. High throughput detection of drug-metabolizing enzyme polymorphisms by allele-specific fluorogenic 5′ nuclease chain reaction assay. Biol. Pharm. Bull. 2000; 23: 1131–1135
   PubMed Web of Science ®Google Scholar
• Holland P. M., Abramson R. D., Watson R., Gelfand D. H. Detection of specific polymerase chain reaction product by utilizing the 5′----3′ exonuclease activity of Thermus aquaticus DNA polymerase. Proc. Natl. Acad. Sci. USA 1991; 88: 7276–7280
   PubMed Web of Science ®Google Scholar
• Ingelman-Sundberg M. Pharmacogenetics of cytochrome P450 and its applications in drug therapy: The past, present and future. Trends Pharmacol. Sci. 2004; 25: 193–200
   PubMed Web of Science ®Google Scholar
• Ingelman-Sundberg M. Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): Clinical consequences, evolutionary aspects and functional diversity. Pharmacogenomics J. 2005; 5: 6–13
   PubMed Web of Science ®Google Scholar
• Ingelman-Sundberg M., Rodriguez-Antona C. Pharmacogenetics of drug-metabolizing enzymes: Implications for a safer and more effective drug therapy. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2005; 360: 1563–1570
   PubMed Web of Science ®Google Scholar
• Johansson I., Lundqvist E., Dahl M. L., Ingelman-Sundberg M. PCR-based genotyping for duplicated and deleted CYP2D6 genes. Pharmacogenetics 1996; 6: 351–355
   PubMedGoogle Scholar
• Kimura S., Umeno M., Skoda R. C., Meyer U. A., Gonzalez F. J. The human debrisoquine 4-hydroxylase (CYP2D) locus: Sequence and identification of the polymorphic CYP2D6 gene, a related gene, and a pseudogene. Am. J. Hum. Genet. 1989; 45: 889–904
   PubMed Web of Science ®Google Scholar
• Kirchheiner J., Fuhr U., Brockmoller J. Pharmacogenetics-based therapeutic recommendations--ready for clinical practice/. Nat. Rev. Drug Discov. 2005; 4: 639–647
   PubMed Web of Science ®Google Scholar
• Kirchheiner J., Nickchen K., Bauer M., Wong M. L., Licinio J., Roots I., Brockmoller J. Pharmacogenetics of antidepressants and antipsychotics: The contribution of allelic variations to the phenotype of drug response. Mol. Psychiatry 2004; 9: 442–473
   PubMed Web of Science ®Google Scholar
• Ledesma M. C., Agundez J. A. Identification of subtypes of CYP2D gene rearrangements among carriers of CYP2D6 gene deletion and duplication. Clin. Chem. 2005; 51: 939–943
   PubMed Web of Science ®Google Scholar
• Lovlie R., Daly A. K., Molven A., Idle J. R., Steen V. M. Ultrarapid metabolizers of debrisoquine: Characterization and PCR-based detection of alleles with duplication of the CYP2D6 gene. FEBS Lett. 1996; 392: 30–34
   PubMed Web of Science ®Google Scholar
• Lundqvist E., Johansson I., Ingelman-Sundberg M. Genetic mechanisms for duplication and multiduplication of the human CYP2D6 gene and methods for detection of duplicated CYP2D6 genes. Gene 1999; 226: 327–338
   PubMed Web of Science ®Google Scholar
• Mattison L. K., Soong R., Diasio R. B. Implications of dihydropyrimidine dehydrogenase on 5-fluorouracil pharmacogenetics and pharmacogenomics. Pharmacogenomics 2002; 3: 485–492
   PubMed Web of Science ®Google Scholar
• McLeod H. L., Siva C. The thiopurine S-methyltransferase gene locus -- implications for clinical pharmacogenomics. Pharmacogenomics 2002; 3: 89–98
   PubMed Web of Science ®Google Scholar
• Meyer U. A., Skoda R. C., Zanger U. M. The genetic polymorphism of debrisoquine/sparteine metabolism-molecular mechanisms. Pharmacol. Ther. 1990; 46: 297–308
   PubMed Web of Science ®Google Scholar
• Mocellin S., Rossi C. R., Pilati P., Nitti D., Marincola F. M. Quantitative real-time PCR: A powerful ally in cancer research. Trends Mol. Med. 2003; 9: 189–195
   PubMed Web of Science ®Google Scholar
• Muller B., Zopf K., Bachofer J., Steimer W. Optimized strategy for rapid cytochrome P450 2D6 genotyping by real-time long PCR. Clin. Chem. 2003; 49: 1624–1631
   PubMed Web of Science ®Google Scholar
• Murphy G. M., Pollock B. G., Kirshner M. A., Pascoe N., Cheuk W., Mulsant B. H., Reynolds C. F. CYP2D6 genotyping with oligonucleotide microarrays and nortriptyline concentrations in geriatric depression. Neuropsychopharmacology 2001; 25: 737–743
   PubMed Web of Science ®Google Scholar
• Phillips K. A., Veenstra D. L., Oren E., Lee J. K., Sadee W. Potential role of pharmacogenomics in reducing adverse drug reactions: A systematic review. JAMA 2001; 286: 2270–2279
   PubMed Web of Science ®Google Scholar
• Pirmohamed M., James S., Meakin S., Green C., Scott A. K., Walley T. J., Farrar K., Park B. K., Breckenridge A. M. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 2004; 329: 15–19
   PubMed Web of Science ®Google Scholar
• Roberts R., Joyce P., Kennedy M. A. Rapid and comprehensive determination of cytochrome P450 CYP2D6 poor metabolizer genotypes by multiplex polymerase chain reaction. Hum. Mutat. 2000; 16: 77–85
   PubMed Web of Science ®Google Scholar
• Roberts R. L., Kennedy M. A. Rapid detection of common cytochrome P450 2D6 alleles in Caucasians. Clin. Chim. Acta 2006; 366: 348–351
   PubMed Web of Science ®Google Scholar
• Schaeffeler E., Schwab M., Eichelbaum M., Zanger U. M. CYP2D6 genotyping strategy based on gene copy number determination by TaqMan real-time PCR. Hum. Mutat. 2003; 22: 476–485
   PubMed Web of Science ®Google Scholar
• Schur B. C., Bjerke J., Nuwayhid N., Wong S. H. Genotyping of cytochrome P450 2D6*3 and *4 mutations using conventional PCR. Clin. Chim. Acta 2001; 308: 25–31
   PubMed Web of Science ®Google Scholar
• Sellner L. N., Taylor G. R. MLPA and MAPH: New techniques for detection of gene deletions. Hum. Mutat. 2004; 23: 413–419
   PubMed Web of Science ®Google Scholar
• Stedman C., Robertson G., Coulter S., Liddle C. Feed-forward regulation of bile acid detoxification by CYP3A4 - Studies in humanized transgenic mice. J. Biol. Chem. 2004; 279: 11336–11343
   PubMed Web of Science ®Google Scholar
• Steen V. M., Andreassen O. A., Daly A. K., Tefre T., Borresen A. L., Idle J. R., Gulbrandsen A. K. Detection of the poor metabolizer-associated CYP2D6(D) gene deletion allele by long-PCR technology. Pharmacogenetics 1995; 5: 215–223
   PubMedGoogle Scholar
• Steijns L. S., Van Der Weide J. Ultrarapid drug metabolism: PCR-based detection of CYP2D6 gene duplication. Clin. Chem. 1998; 44: 914–917
   PubMed Web of Science ®Google Scholar
• Stuven T., Griese E. U., Kroemer H. K., Eichelbaum M., Zanger U. M. Rapid detection of CYP2D6 null alleles by long distance- and multiplex-polymerase chain reaction. Pharmacogenetics 1996; 6: 417–421
   PubMedGoogle Scholar
• Topic E., Stefanovic M., Ivanisevic A. M., Blazinic F., Culav J., Skocilic Z. CYP2D6 genotyping in patients on psychoactive drug therapy. Clin. Chem. Lab. Med. 2000; 38: 921–927
   PubMed Web of Science ®Google Scholar
• Wilhelm J., Pingoud A. Real-time polymerase chain reaction. ChemBioChem 2003; 4: 1120–1128
   PubMed Web of Science ®Google Scholar
• Zanger U. M., Raimundo S., Eichelbaum M. Cytochrome P450 2D6: Overview and update on pharmacology, genetics, biochemistry. Naunyn Schmiedebergs Arch. Pharmacol. 2004; 369: 23–37
   PubMed Web of Science ®Google Scholar